Friday, January 20, 2012

BREAKING NEWS: More unexpected new anti-cancer drug side-effects discovered after patients use Melanoma drug, vermurafenib (Zelboraf)

This is a bit disturbing...

Melanoma drug's link to other skin cancers identified

By Madonna Behen, HealthDay and USA Today

The recently approved drug vemurafenib (Zelboraf) has been hailed as a breakthrough in the treatment of melanoma, the deadliest form of skin cancer. But roughly one-quarter of patients who take the medication develop a troublesome side effect: secondary skin cancers called squamous cell carcinomas.

Click HERE to read more.

Two steps forward, one step back...

Feel good and keep smiling!  Pat



No comments:

Post a Comment